These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15794718

  • 21. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
    Wilt TJ, Niewoehner D, MacDonald R, Kane RL.
    Ann Intern Med; 2007 Nov 06; 147(9):639-53. PubMed ID: 17975187
    [Abstract] [Full Text] [Related]

  • 22. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
    Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J.
    Chest; 2007 Mar 06; 131(3):682-689. PubMed ID: 17356080
    [Abstract] [Full Text] [Related]

  • 23. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Lung; 2006 Mar 06; 184(4):217-22. PubMed ID: 17006748
    [Abstract] [Full Text] [Related]

  • 24. Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients.
    Soriano JB, Kiri VA, Pride NB, Vestbo J.
    Am J Respir Med; 2003 Mar 06; 2(1):67-74. PubMed ID: 14720023
    [Abstract] [Full Text] [Related]

  • 25. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
    Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Rousseau R, ABC (Advair, Biomarkers in COPD) Investigators.
    BMC Pulm Med; 2006 Feb 06; 6():3. PubMed ID: 16460562
    [Abstract] [Full Text] [Related]

  • 26. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr 06; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 27. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
    Fuso L, Mores N, Valente S, Malerba M, Montuschi P.
    Curr Med Chem; 2013 Apr 06; 20(12):1477-95. PubMed ID: 23409722
    [Abstract] [Full Text] [Related]

  • 28. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H, Yoshikawa T, Hirata K.
    Nihon Rinsho; 2007 Apr 06; 65(4):696-701. PubMed ID: 17419390
    [Abstract] [Full Text] [Related]

  • 29. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
    Cazzola M, Dahl R.
    Chest; 2004 Jul 06; 126(1):220-37. PubMed ID: 15249466
    [Abstract] [Full Text] [Related]

  • 30. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y, Nagasaka Y.
    Clin Calcium; 2007 Jun 06; 17(6):955-62. PubMed ID: 17548937
    [Abstract] [Full Text] [Related]

  • 31. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?
    Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou-Grigoriadou V, Siasos G, Evangelopoulou E, Mathioudakis GA.
    Respirology; 2013 Jan 06; 18(1):147-53. PubMed ID: 22985270
    [Abstract] [Full Text] [Related]

  • 32. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
    Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Vestbo J.
    Lancet; 2016 Sep 03; 388(10048):963-73. PubMed ID: 27598678
    [Abstract] [Full Text] [Related]

  • 33. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
    Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C, TRial of Inhaled STeroids ANd long-acting beta2 agonists study group.
    Lancet; 2003 Feb 08; 361(9356):449-56. PubMed ID: 12583942
    [Abstract] [Full Text] [Related]

  • 34. COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care.
    Thomas M, Radwan A, Stonham C, Marshall S.
    COPD; 2014 Jun 08; 11(3):300-9. PubMed ID: 24152210
    [Abstract] [Full Text] [Related]

  • 35. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.
    Kwak MS, Kim E, Jang EJ, Kim HJ, Lee CH.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 08; 10():2365-76. PubMed ID: 26604734
    [Abstract] [Full Text] [Related]

  • 36. Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks.
    McEvoy CE, Niewoehner DE.
    Clin Chest Med; 2000 Dec 08; 21(4):739-52. PubMed ID: 11194783
    [Abstract] [Full Text] [Related]

  • 37. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409
    [Abstract] [Full Text] [Related]

  • 38. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 19; 11():1921-8. PubMed ID: 27574416
    [Abstract] [Full Text] [Related]

  • 39. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 19; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 40. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L, Cates CJ, Lasserson TJ, Poole P.
    Cochrane Database Syst Rev; 2004 Apr 19; (3):CD003794. PubMed ID: 15266502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.